Lemaitre Vascular (LMAT) EBT (2010 - 2026)

Lemaitre Vascular (LMAT) has reported EBT for 17 consecutive years, with $22.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT rose 22.79% year-over-year to $22.2 million in Q2 2026; TTM through Jun 2026 was $84.7 million, a 39.18% increase from a year earlier, with the FY2025 full-year figure at $75.2 million, up 32.19% from the prior year.
• EBT was $22.2 million for Q2 2026 at Lemaitre Vascular, up from $19.7 million in the prior quarter.
• Over five years, EBT peaked at $22.6 million in Q3 2025 and troughed at $5.5 million in Q2 2022.
• A 5-year average of $13.4 million and a median of $13.4 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT tumbled 46.93% in 2022 and surged 85.99% in 2023, its largest moves.
• Over 5 years, EBT stood at $7.8 million in 2022, then jumped by 45.08% to $11.3 million in 2023, then rose by 23.94% to $14.0 million in 2024, then soared by 44.78% to $20.3 million in 2025, then gained by 9.31% to $22.2 million in 2026.
• The last three EBT figures came in at $22.2 million (Q2 2026), $19.7 million (Q1 2026), and $20.3 million (Q4 2025), per Business Quant data.